---
figid: PMC2949386__pone.0013131.g006
figtitle: Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum
  Activity
organisms:
- Lareunionomyces loeiensis
- Olea europaea
- Arachis hypogaea
- Bos taurus
- Oryctolagus cuniculus
- Homo sapiens
- Mus musculus
- Trypanosoma cruzi
organisms_ner:
- Mus musculus
- Homo sapiens
- Bos taurus
- Oryctolagus cuniculus
- Drosophila melanogaster
pmcid: PMC2949386
filename: pone.0013131.g006.jpg
figlink: /pmc/articles/PMC2949386/figure/pone-0013131-g006/
number: F6
caption: Molecules in green are down-regulated in our microarray results while those
  in red are up-regulated. Proteins whose phosphorylation level was affected by TP421
  treatment are denoted by *.
papertitle: Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum
  Activity.
reftext: Melissa Millard, et al. PLoS One. 2010;5(10):e13131.
year: '2010'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9105016
figid_alias: PMC2949386__F6
figtype: Figure
redirect_from: /figures/PMC2949386__F6
ndex: 85ca31ae-df11-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2949386__pone.0013131.g006.html
  '@type': Dataset
  description: Molecules in green are down-regulated in our microarray results while
    those in red are up-regulated. Proteins whose phosphorylation level was affected
    by TP421 treatment are denoted by *.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Hgf
  - Met
  - Grb2
  - ras
  - Hras
  - Kras
  - Rem1
  - Ptk2
  - Pxn
  - Ptpn11
  - Pik3r1
  - Hspg2
  - Terf2ip
  - Rap1a
  - Raf1
  - Ear1
  - Crkl
  - Akt1
  - Map3k1
  - Map2k4
  - Map2k7
  - Mapk3
  - Mapk1
  - Mapk8
  - Stat3
  - Jun
  - Fos
  - Ptgs2
  - HGF
  - IL6
  - SOS1
  - XYLT2
  - SOS2
  - GRB2
  - KRAS
  - HRAS
  - NRAS
  - PTK2
  - PXN
  - PXDN
  - PTPN11
  - A1BG
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - RAP1A
  - RABGEF1
  - TERF2IP
  - RAP1B
  - RAF1
  - RNASE3
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - CRKL
  - AKT1
  - AKT2
  - AKT3
  - MAP3K1
  - MAP2K4
  - MAP2K7
  - MAPK3
  - MAPK1
  - MAPK8
  - MAPK9
  - MAPK10
  - STAT3
  - JUN
  - JUNB
  - JUND
  - ETS1
  - ETS2
  - ABCC6
  - FOXC1
  - PAK3
  - FOS
  - FOSB
  - FOSL1
  - FOSL2
  - PTGS2
  - scb
  - Sos
  - drk
  - Ras64B
  - Ras85D
  - Fak
  - Pax
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - norpA
  - sl
  - Plc21C
  - AP-1gamma
  - gammaTry
  - E(spl)mgamma-HLH
  - Rap1
  - Raf
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Akt
  - Mekk1
  - cer
  - Mkk4
  - hep
  - rl
  - bsk
  - Jra
  - Ets21C
  - Ets65A
  - pnt
  - Ets96B
  - Ets97D
  - Ets98B
  - ara
  - kay
  - CycE
  - cyc
  - LanB2
  - anon-70Db
  - Cancer
  - Noonan syndrome
---
